QA: Skye Bioscience Inc. in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001516551_2021_Skye_Bioscience_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001516551')"}

Graph

Absolute values for 0001516551, Skye Bioscience Inc.

  xvar xval
0 AssetsCurrent 2,664,385
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 7,341
3 remainder_Assets 0
4 LiabilitiesCurrent 787,199
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 1,433,741
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 4,344,602
9 ResearchAndDevelopmentExpense 1,944,411
10 remainder_Expenses 1,600
11 remainder_Revenues 0
12 remainder_NetIncome -270,086
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 2,671,726
1 Liabilities 2,220,940
2 Expenses 6,290,613
3 Revenues 0
4 StockholdersEquity 450,786
5 NetIncome -6,560,699
6 ComprehensiveNetIncome -6,560,699
7 BaseVar 5,726,682
8 EconomicCapitalRatio -2.36

Edgar->Model Mapping

Feature Distribution

Change over Time